News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Actavis (ACT), Warner Chilcott, PLC (WCRX) Leap by Double Digits on Merger Talk


5/13/2013 8:04:46 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Drugmakers Actavis Inc. and Warner Chilcott PLC said Friday that they in early talks about a possible combination of the two companies. Both say there is no agreement on a deal yet. Shares of both companies soared in Friday trading. Actavis was formed in October through a $5.6 billion combination of Watson Pharmaceuticals of New Jersey and Actavis of Switzerland. It is one of the world's biggest generic drug companies. It sells versions of the deep vein thrombosis treatment Lovenox, asthma medication Xopenex, attention deficit hyperactivity disorder drugs Adderall XR and Concerta, heart drug Toprol XL, cholesterol fighter Lipitor, contraceptive Generess FE, and pain drug Kadian among many other products.

Help employers find you! Check out all the jobs and post your resume.

Read at CBS News
Read at Huffington Post
Read at nj.com
Read at Wall Street Journal

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES